Skip to main content
XGN
NASDAQ Life Sciences

Exagen Beats Q2 Revenue by 12%, Raises 2026 Outlook on Test Volume Surge

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$5.6
Mkt Cap
$113.068M
52W Low
$2.59
52W High
$12.23
52W Position info
116% above low
Off High info
54% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

XGN has more than doubled off its 52-week low of $2.59.

Summary

Exagen delivered a strong Q2, with revenue of $19.94M beating consensus by 12% on 11% test volume growth and a 4% ASP increase. The company raised full-year 2026 revenue guidance to $72M-$75M, signaling confidence in sustained demand for its AVISE lupus diagnostics. Net loss narrowed nearly 30% to $3.2M, and adjusted EBITDA loss shrank to just $0.1M, putting breakeven within reach. This follows a Q1 beat in May and recent validation of AVISE Lupus performance, reinforcing the commercial momentum. With a $113M market cap and shares at $5.60, the raised outlook and improving margins could drive further re-rating.

At the time of this announcement, XGN was trading at $5.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $113.1M. The 52-week trading range was $2.59 to $12.23. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

XGN - Latest Insights

XGN
Nov 10, 2026, 9:49 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.26
Real-time Price: $3.76 info
Change: -$1.50 (-29%) info
Market Cap: $95.931M info
XGN
Nov 10, 2026, 9:33 AM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $5.83
Real-time Price: $3.76 info
Change: -$2.07 (-36%) info
Market Cap: $95.931M info
XGN
Nov 10, 2026, 9:01 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.55
Real-time Price: $3.76 info
Change: -$2.79 (-43%) info
Market Cap: $95.931M info
XGN
Nov 10, 2026, 7:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $7.59
Real-time Price: $3.76 info
Change: -$3.83 (-50%) info
Market Cap: $95.931M info
XGN
Aug 04, 2026, 9:15 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.66
Real-time Price: $3.76 info
Change: -$1.90 (-34%) info
Market Cap: $95.931M info